RecallDepth
Class II Completed

Duloxetine Delayed-Release Capsules, USP, 20mg, Rx Only, 500-count bottles, Mfr. by: Towa Pharmaceutical Europe, S.L. Distributed by: BPI, NDC 51991-746-05.

Company
Breckenridge Pharmaceutical, Inc
Recall Initiated
October 10, 2024
Posted
October 23, 2024
Recall Number
D-0009-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
7,107 bottles
Firm Location
Berlin, CT, United States

Reason for Recall

CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit

Distribution

Product was distributed nationwide within the United States

Lot / Code Info

Lot #: 220128, Exp. Date 12/2024

More recalls by Breckenridge Pharmaceutical, Inc

View all recalls by this company →

Other recent Class II Drug recalls